Once it is taken up by CD8 T cells, the glycolytic enzyme LDH will directly target it to drive a metabolic program and impair their proliferation, cytotoxicity and interferon-γ signaling with mouse tumor models (Nathan, 2022). This evidence concerns the gene CD8A and neoplasm.